Severe uterine atrophy after adenomyomectomy: Implications for potential risks to infertile patients with diffuse adenomyosis
article
OA: bronze
CC0
AI-generated summary
This review of existing literature discusses severe uterine atrophy as a potential risk following adenomyomectomy in infertile patients with diffuse adenomyosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The authors have no conflicts of interest. Data sharing is not applicable to this article as no new data were created or analyzed in this study.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (7)
- Clinical efficacy of a novel method of fertility-preserving adenomyomectomy in infertile women with diffuse adenomyosis via openalex
- Conservative surgery of diffuse adenomyosis with TOUA: Single surgeon experience of one hundred sixteen cases and report of fertility outcomes via openalex
- Conservative surgical management for diffuse uterine adenomyosis via openalex
- Long-Term Pregnancy Outcomes of Patients with Diffuse Adenomyosis after Double-Flap Adenomyomectomy via openalex
- Surgical procedure to conserve the uterus for future pregnancy in patients suffering from massive adenomyosis via openalex
- The Effect of Uterine Adenomyosis on IVF Outcomes: a Systematic Review and Meta-analysis via openalex
- Treatment of adenomyomectomy in women with severe uterine adenomyosis using a novel technique via openalex
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-27T00:31:25.178224+00:00
License: CC0
· commercial use OK